In a state of crisis: Liability ills continue amid reform efforts
As medical liability insurance policies come up for renewal and legislators work on reforming the system, physicians and other observers say the nation's liability insurance crisis is worsening. The most promising solution appears to be reform at the federal level, although relief will not come soon, according to national and local physician groups, government officials, insurers, and others familiar with the situation.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.
Drug extends survival in prostate cancer with genetic mutations
December 8th 2023“Our analysis suggests that there is superior clinical benefit with olaparib versus control both in patients who had and had not received previous taxane treatment,” said Maha Hussain, MD, Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
